This volume covers the emerging area of science, Clinical Lipidomics, which is the application of lipidology to the understanding of physiological and pathophysiological changes of lipidomes, with a special focus on lipidomic profiles in human diseases.Lipidomics is widely used to map lipid molecular species in a biological system. Clinical lipidomic analysis has demonstrated the comprehensive characterization of molecular lipids in various severities, durations, and therapies as a critical tool in identification and validation of disease-specific biomarkers. This volume on Clinical Lipidomics will add to the literature and help advance the knowledge of the pathogenesis, diagnosis, prevention and treatment of diseases. 

Chapter 1. Clinical Lipidomics: A Critical Approach for Disease Diagnosis and Therapy.- Chapter 2. The role of lipid metabolism in the development of lung cancer.- Chapter 3. Bioinformatics of Embryonic Exposures: Lipid Metabolism and Gender as Biomedical Variables.- Chapter 4. An Evaluation of Multivariate Data Analysis Models for Lipidomic Parameters from Patients with Metabolic Syndrome Undergoing Remedial Treatment.- Chapter 5. Lipidomics in carotid artery stenosis: further understanding of pathology and treatment.- Chapter 6. Metabolomics of Immunity and Its Clinical Applications.- Chapter 7. Urinary Lipidomics.- Chapter 8. Breast cancer and lipid metabolism.- Chapter 9. Association of circulating oxidized lipids with cardiovascular outcomes.- Chapter 10. Lipidomics: Mass Spectrometry Based Untargeted Profiling and False Positives.- Chapter 11. Phospholipid and Phospholipidomics in Health and Diseases.